"For us at Trygg-Hansa it is extremely important that our customers have access to the best possible quality of care and get the best possible service. The cooperation with GHP strengthens our ambition and we are pleased to now be able to start this joint journey," says Pierre Schuster, Head of Corporate division at Trygg-Hansa.

This strategic collaboration means that GHP is responsible for all care of Trygg-Hansa's patients with musculoskeletal problems (knee, hip, shoulder, spine, hand or foot). In contrast with how health care is traditionally purchased, with the focus on cost per measure taken, this collaboration focuses on quality outcomes, preventive work, service and total health care costs for the population. Through the business area Vårdsamverkan, GHP is responsible for the purchase and control of all care, which is then provided by both GHP's own clinics and external clinics.

"This collaboration is incredibly exciting. For us it means that together with a good collaboration partner we can develop the full potential of Vårdsamverkan. When we focus on quality outcomes and entire care chains we can achieve considerable improvements in health care," says Daniel Öhman, CEO of GHP.

Financially this means that sales in Vårdsamverkan will increase by SEK 40-60 million per year. Approximately 30% of these sales already exist today in GHP's clinics, and this percentage is expected to increase from the collaboration. For GHP Vårdsamverkan, the agreement is not expected to have any major positive effect during 2018 as investments in IT, process and general business development are planned. Profitability in the clinics from additional sales is expected to be in line with existing profit margins. The agreement is effective as of 1 July 2018.

16 April 2018
Gothenburg
GHP Specialty Care AB (publ)